Difference between revisions of "Team:Sherbrooke/Parts"

(Prototype team page)
 
 
(11 intermediate revisions by 3 users not shown)
Line 3: Line 3:
  
 
<h2> Part Documentation</h2>
 
<h2> Part Documentation</h2>
 
+
<hr>
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
<hr>
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
<p style=text-align:justify>
 
+
Every single parts are designed to adapt the recombineering technique onto the BIOBOT platform. The fiability of our parts should enable the full automization of the recombineering process, a first step in MAGE automatization. To do so, we have built kill switches and positive selection markers to help a robot picking only the right colonies through easy and visual reporters and selectable markers.
 
+
</p>
<div class="highlightBox">
+
<br>
<h4>Note</h4>
+
<span id="BBa_K1744000"> &nbsp; </span>
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
<h3>BBa_K1744000</h3>
</div>
+
<hr>
 
+
<p style=text-align:justify>
 
+
<img src="https://static.igem.org/mediawiki/2015/7/7e/BBa_K1744000_1.png" style="float:left;width:200px;height:50px;">
 
+
<a href="http://parts.igem.org/Part:BBa_K1744000">This part</a> is designed for clean deletion recombineering experiments. It has an arabinose induced toxin for negative selection and an ampicillin resistance gene for positive selection. This part is designed to be amplified using primer with homology to the targeted region and then integrated in that region using lambda red recombineering systems available commercially such as the heat-inducible pSIM plasmid family. The toxin vcrx028 is toxic for the cell. To repress its expression you must put glucose in the medium (we use 5%w/v). To activate the arabinose kill switch, we use 1 %w/v arabinose in the medium. To do the clean deletion (without DNA scar in the sequence) through recombineering, you must first insert the cassette in the genome by recombination, causing the deletion, and select the recombinants with ampicillin without forgetting to use a medium containing glucose to avoid unwanted toxin expression. Then you have to make the cassette pop out by recombineering using a fusion PCR of both adjacent regions to the one you want to delete and counterselect the cells that did not lose the part with arabinose (triggering the kill switch).
<h4>Adding parts to the registry</h4>
+
</p>
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
<br>
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
<span id="BBa_K1744001"> &nbsp; </span>
 
+
<h3>BBa_K1744001</h3>
 
+
<hr>
<h4>What information do I need to start putting my parts on the Registry?</h4>
+
<p style=”text-align:justify”>
<p>The information needed to initially create a part on the Registry is:</p>
+
<img src="https://static.igem.org/mediawiki/2015/3/35/BBa_K1744001_1.png" style="float:left;width:114px;height:27px;">
 +
<a href="http://parts.igem.org/Part:BBa_K1744001">This part</a> is a positive selection system for recombineering. It contains a kanamycin resistance gene Aph(3’)-I (aminoglycoside 3’-phosphotransferase, truncated version) with its native promoter as well as amilCP, a deep blue chromoprotein. amilCP gene is under the control of a strong constitutive promoter with a strong RBS to make it more intense than previous versions. The cassette is designed to be a double positive selection marker for recombineering. Once amplified with primer bearing homology to the targeted region, the cassette can be integrated in the genome through lambda red recombination. Once integrated, the colonies should become resistant to kanamycin and become pale blue overtime. However, the blue color is actually faint and really slow to become apparent.
 +
</p>
 +
<br>
 +
<span id="BBa_K1744002"> &nbsp; </span>
 +
<h3>BBa_K1744002</h3>
 +
<hr>
 +
<p style=text-align:justify>
 +
<img src="https://static.igem.org/mediawiki/2015/d/d9/BBa_K1744002_1.png" style="float:left;width:250px;height:50px;">
 +
<a href="http://parts.igem.org/Part:BBa_K1744002">This part</a> is a fully autonomous arabinose kill switch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls the expression of <i>vcrx028</i> (a toxin) through the promoter PBAD. This promoter is inducible with arabinose and can be repressed with glucose (final concentration of 1 and 5%w/v, respectively). <i>vcrx028</i> is a toxin gene isolated from pVCR94, a conjugative plasmid discovered in the cholera outbreak of 1994 in a Rwanda refugee camp. Then there is amilCP, a chromoprotein isolated from Acropora millepora that serves as a selection marker. Finally, we have the kanamycin resistance gene which is Aph(3’)-I (aminoglycoside 3’-phosphotransferase) and originate from pOK12. It was selected because the coding sequence had a deletion, making the sequence smaller. This is of particular importance for our project because we use this part for recombineering, which is greatly impaired if the length of the cassette used is bigger than 1.5 kb. This part is designed to be used in a recombineering experiment to make a clean deletion where no scars such as FRT sites are left from the experiment. To do so, we first delete the targeted region with our cassette amplified with homology on both sides of the region to delete and then use a medium with glucose (to repress the toxin) and with kanamycin 50 µg/mL to select the recombinants. Then, using a fusion PCR of both sides of the deletion, the cassette is removed and we can counterselect with arabinose (which induce the toxin and kills cells that did not recombined).To minimize the cassette length and maximize the recombination frequencies we recommend using phosphothiolated primers, 80 bp homologies at least on both sides of the targeted region, only use the part of the cassette PBAD-vcrx028-P1U2-amilCP-KanR and do the recombineering in a cell containing a plasmidic araC expression. Since amilCP’s expression is not strong enough to really be visible in a genomic context, unlike plasmidic context, amilCP protein production may therefore serve as an easy plasmid detection system to eliminate plasmidic background that could occur during recombineering experiments. The system is designed so it is easy to select the good cells with the correct phenotype and speed up the screening process that is often the longest part of the experiment.
 +
</p>
 +
<br>
 +
<h2>Also in "Parts"</h2>
 +
<hr>
 
<ul>
 
<ul>
<li>Part Name</li>
+
<a href="https://2015.igem.org/Team:Sherbrooke/Basic_Part"><li>Basic Parts</li></a>
<li>Part type</li>
+
<a href="https://2015.igem.org/Team:Sherbrooke/Composite_Part"><li>Composite Parts</li></a>
<li>Creator</li>
+
<a href="https://2015.igem.org/Team:Sherbrooke/Part_Collection"><li>Parts Collection</li></a>
<li>Sequence</li>
+
<li>Short Description (60 characters on what the DNA does)</li>
+
<li>Long Description (Longer description of what the DNA does)</li>
+
<li>Design considerations</li>
+
 
</ul>
 
</ul>
 +
<hr>
 +
<hr>
  
<p>
 
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
 
 
 
 
 
 
 
<h4>Inspiration</h4>
 
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
 
 
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
 
<ul>
 
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
 
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
 
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
 
</ul>
 
 
 
 
<h4>Part Table </h4>
 
</html>
 
<groupparts>iGEM015 Example</groupparts>
 
<html>
 
 
 
 
</div>
 
 
</html>
 
</html>

Latest revision as of 17:32, 18 September 2015

Part Documentation



Every single parts are designed to adapt the recombineering technique onto the BIOBOT platform. The fiability of our parts should enable the full automization of the recombineering process, a first step in MAGE automatization. To do so, we have built kill switches and positive selection markers to help a robot picking only the right colonies through easy and visual reporters and selectable markers.


 

BBa_K1744000


This part is designed for clean deletion recombineering experiments. It has an arabinose induced toxin for negative selection and an ampicillin resistance gene for positive selection. This part is designed to be amplified using primer with homology to the targeted region and then integrated in that region using lambda red recombineering systems available commercially such as the heat-inducible pSIM plasmid family. The toxin vcrx028 is toxic for the cell. To repress its expression you must put glucose in the medium (we use 5%w/v). To activate the arabinose kill switch, we use 1 %w/v arabinose in the medium. To do the clean deletion (without DNA scar in the sequence) through recombineering, you must first insert the cassette in the genome by recombination, causing the deletion, and select the recombinants with ampicillin without forgetting to use a medium containing glucose to avoid unwanted toxin expression. Then you have to make the cassette pop out by recombineering using a fusion PCR of both adjacent regions to the one you want to delete and counterselect the cells that did not lose the part with arabinose (triggering the kill switch).


 

BBa_K1744001


This part is a positive selection system for recombineering. It contains a kanamycin resistance gene Aph(3’)-I (aminoglycoside 3’-phosphotransferase, truncated version) with its native promoter as well as amilCP, a deep blue chromoprotein. amilCP gene is under the control of a strong constitutive promoter with a strong RBS to make it more intense than previous versions. The cassette is designed to be a double positive selection marker for recombineering. Once amplified with primer bearing homology to the targeted region, the cassette can be integrated in the genome through lambda red recombination. Once integrated, the colonies should become resistant to kanamycin and become pale blue overtime. However, the blue color is actually faint and really slow to become apparent.


 

BBa_K1744002


This part is a fully autonomous arabinose kill switch with a kanamycin resistance gene (truncated version) and amilCP. The araC gene is driven by its native promoter. It controls the expression of vcrx028 (a toxin) through the promoter PBAD. This promoter is inducible with arabinose and can be repressed with glucose (final concentration of 1 and 5%w/v, respectively). vcrx028 is a toxin gene isolated from pVCR94, a conjugative plasmid discovered in the cholera outbreak of 1994 in a Rwanda refugee camp. Then there is amilCP, a chromoprotein isolated from Acropora millepora that serves as a selection marker. Finally, we have the kanamycin resistance gene which is Aph(3’)-I (aminoglycoside 3’-phosphotransferase) and originate from pOK12. It was selected because the coding sequence had a deletion, making the sequence smaller. This is of particular importance for our project because we use this part for recombineering, which is greatly impaired if the length of the cassette used is bigger than 1.5 kb. This part is designed to be used in a recombineering experiment to make a clean deletion where no scars such as FRT sites are left from the experiment. To do so, we first delete the targeted region with our cassette amplified with homology on both sides of the region to delete and then use a medium with glucose (to repress the toxin) and with kanamycin 50 µg/mL to select the recombinants. Then, using a fusion PCR of both sides of the deletion, the cassette is removed and we can counterselect with arabinose (which induce the toxin and kills cells that did not recombined).To minimize the cassette length and maximize the recombination frequencies we recommend using phosphothiolated primers, 80 bp homologies at least on both sides of the targeted region, only use the part of the cassette PBAD-vcrx028-P1U2-amilCP-KanR and do the recombineering in a cell containing a plasmidic araC expression. Since amilCP’s expression is not strong enough to really be visible in a genomic context, unlike plasmidic context, amilCP protein production may therefore serve as an easy plasmid detection system to eliminate plasmidic background that could occur during recombineering experiments. The system is designed so it is easy to select the good cells with the correct phenotype and speed up the screening process that is often the longest part of the experiment.


Also in "Parts"